Synthetic Cannabinoids Market by Product Type (High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids) by Indication (Nausea/Vomiting, Neurological Disorder Management, Pain Management, Others) by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 24-Feb-2021 Category: Chemical & Materials Report Format : PDF Pages: 110 Report Code: ZMR-5858 Status : Published

The synthetic cannabinoids market is set for a rapid growth over the forecast period. In terms of revenue, the global synthetic cannabinoids market accounted for USD 1,904.7 Million in 2019 and is expected to reach USD 7,556.9 Million by 2026, growing at a CAGR of 21.76%

Description

The synthetic cannabinoids market is set for a rapid growth over the forecast period. In terms of revenue, the global synthetic cannabinoids market accounted for USD 1,904.7 Million in 2019 and is expected to reach USD 7,556.9 Million by 2026, growing at a CAGR of 21.76%

Global Synthetic Cannabinoids Market: Overview

Synthetic cannabinoids are psychoactive drug produced by humans, which are often sprayed on dried plant matter so that they can be smoked in e-cigarettes or other smokable products to be vaped (inhaled/exhaled). These products are sometimes referred to as, "herbal smoking blends" or "herbal incense".

Since they are similar to chemicals present in the marijuana plants, these chemicals are called cannabinoids. Synthetic cannabinoids are often misleadingly referred to as synthetic marijuana/cannabis or "fake weed" because of this resemblance, and they are sometimes advertised as harmless, legal alternatives to that drug. In reality, they are not harmless and can affect the brain even more strongly than marijuana. The actual implications could be uncertain and, in some cases, more damaging or even life-threatening.

Global Synthetic Cannabinoids Market: Growth Factors

The growth of global demand for synthetic cannabinoids is anticipated to position its demands on the regulatory framework for the use of synthetic cannabinoid drugs. The rising popularity of e-cigarettes combined with the increasing inclination to the use of synthetic cannabinoids as a replacement to non-synthetic cannabis in many parts of the world is expected to provide a major boost to the use of synthetic cannabinoids.

In addition, synthetic cannabinoids are promoted as a safe and legal substitute to marijuana in many parts of the world, as a result of which the selling of synthetic cannabinoids has seen development, especially among the millennial generation. However, rising concern about the effects of synthetic cannabinoid use and growing evidence of the harmful influence of synthetic cannabinoids on the human mind are some of the main factors expected to impede the growth of the global market for synthetic cannabinoids in the coming years.

Increased consumer awareness and growth for non-regulated psychoactive substances over the last few years is projected to fuel the global synthetic cannabinoids market during the forecast era. The need for synthetic cannabinoids to determine the possible effect of a wide variety of diseases and symptoms, particularly neurodegenerative diseases, drug dependency, cancer, and pain disorders is another significant factor likely to drive the demand for global synthetic cannabinoids market.

The regulatory framework for the production and consumption of synthetic cannabinoids in different regions is yet another major factor expected to affect the overall growth of the global market for synthetic cannabinoids during the assessment era. Research and development activities are expected to play an important role in supporting and raising awareness of the possible medical benefits of synthetic cannabinoids, thereby fueling the demand for synthetic cannabinoids in the coming decade.

Impact due to the outbreak of COVID-19

Sales of synthetic cannabinoids, particularly in 2020, are projected to be hampered by the onset of the new COVID-19 pandemic. Growing understanding of the novel infection of COVID-19 and its impact on the human respiratory system is one of the primary drivers that is expected to impede sales of synthetic cannabinoids by 2020. Moreover, strict government laws on the trade and transport of non-essential goods and services in many parts of the world are a key reason that is expected to hinder the global supply chain of synthetic cannabinoids in 2020.

Global Synthetic Cannabinoids Market: Segmentation

On the basis of product type, the global synthetic cannabinoids market is categorized into ultra-pure synthetic cannabinoids and high-pure synthetic cannabinoids. The market has been dominated by the high-pure synthetic cannabinoid module in 2019, owing to the fact that they were launched earlier on the market and are widely accepted for the treatment of serious illnesses such as multiple sclerosis, insomnia, and epilepsy.

Based on indication, the global synthetic cannabinoids market is classified into pain relief, nausea/vomiting, management of neurological disorders, and others. In 2019, the pain management sector held the largest market share in 2019, as the rate of neurological pain occurrence has risen globally due to an increase in illness, injuries, or surgery.

In terms of distribution channel, the global synthetic cannabinoids market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. In 2019, the retail pharmacy division accounted for a significant market share. Owing to reasonable pricing of products, the segment is estimated to gain market share over the forecast period. In addition, significant benefits offered by the products boost sales. These factors are likely to propel the segment in the near future.

Global Synthetic Cannabinoids Market: Regional Analysis

By Geography, the synthetic cannabinoids market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

The demand for synthetic cannabinoids in North America is expected to develop rapidly during the forecast timeframe. This can be due to the large availability of products and the continuous promotion of its brand among medical professionals in the region by the involvement of major companies. In addition, recent FDA approvals of cannabidiol products in the United States for the treatment of two serious types of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome is also expected to fuel the market demand in the region.

In Europe, the global synthetic cannabinoids market is anticipated to grow at a significant pace, due to an increase in the use of synthetic cannabinoids among cancer patients and increased knowledge of therapy, particularly in developed countries in Europe where research and development activities are strong, such as Germany, the United Kingdom and France.

In Asia-Pacific, India and China are leading pharmaceutical and drug markets where synthetic cannabinoid approval for pharmaceutical formulations may play a major role in promoting the sales of synthetic cannabinoids in the region.

Global Synthetic Cannabinoids Market: Competitive Players

The major players in the global synthetic cannabinoids market include Mylan N.V., Noramco, Lygos, Inc., Alkem Labs, BOTANIX PHARMACEUTICALS, Hyasynth Biologicals, Inc., INSYS THERAPEUTICS, INC, Renew Biopharma, CannBioRx Life Sciences, Ginkgo Bioworks, CURE Pharmaceutical, Aphios Corporation, and Zynerba Pharmaceuticals, Inc. among others.

The report segment of global synthetic cannabinoids market are as follows:

Global Synthetic Cannabinoids Market: Product Type Segment Analysis

  • High-Pure Synthetic Cannabinoids
  • Ultra-Pure Synthetic Cannabinoids

Global Synthetic Cannabinoids Market: Indication Segment Analysis

  • Nausea/Vomiting
  • Neurological Disorder Management
  • Pain Management
  • Others

Global Synthetic Cannabinoids Market: Distribution Channel Segment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Synthetic Cannabinoids Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Synthetic Cannabinoids Market, 2016-2026, (USD Million)
    • 2.2. Synthetic Cannabinoids Market: Market snapshot
  • Chapter 3. Global Synthetic Cannabinoids Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Technulogy landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & sustainability
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Synthetic Cannabinoids Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Product Type Segment
      • 3.11.2. Market Attractiveness Analysis by Indication Segment
      • 3.11.3. Market Attractiveness Analysis by Distribution Channel Segment
  • Chapter 4. Global Synthetic Cannabinoids Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Synthetic Cannabinoids Market – Product Type Segment Analysis
    • 5.1. Global Synthetic Cannabinoids Market Revenue Share, by Product Type, 2019 & 2026 (USD Million)
    • 5.2. Global Synthetic Cannabinoids Market by High-Pure Synthetic Cannabinoids, 2016 – 2026 (USD Million)
    • 5.3. Global Synthetic Cannabinoids Market by Ultra-Pure Synthetic Cannabinoids, 2016 – 2026 (USD Million)
  • Chapter 6. Synthetic Cannabinoids Market – Indication Segment Analysis
    • 6.1. Global Synthetic Cannabinoids Market Revenue Share, by Indication, 2019 & 2026 (USD Million)
    • 6.2. Global Synthetic Cannabinoids Market by Nausea/Vomiting, 2016 – 2026 (USD Million)
    • 6.3. Global Synthetic Cannabinoids Market by Neurulogical Disorder Management, 2016 – 2026 (USD Million)
    • 6.4. Global Synthetic Cannabinoids Market by Pain Management, 2016 – 2026 (USD Million)
    • 6.5. Global Synthetic Cannabinoids Market by Others, 2016 – 2026 (USD Million)
  • Chapter 7. Synthetic Cannabinoids Market – Distribution Channel Segment Analysis
    • 7.1. Global Synthetic Cannabinoids Market Revenue Share, by Distribution Channel, 2019 & 2026 (USD Million)
    • 7.2. Global Synthetic Cannabinoids Market by Hospital Pharmacies, 2016 – 2026 (USD Million)
    • 7.3. Global Synthetic Cannabinoids Market by Retail Pharmacies, 2016 – 2026 (USD Million)
    • 7.4. Global Synthetic Cannabinoids Market by Online Pharmacies, 2016 – 2026 (USD Million)
  • Chapter 8. Synthetic Cannabinoids Market - Regional Analysis
    • 8.1. Global Synthetic Cannabinoids Market: Regional Overview
      • 8.1.1. Global Synthetic Cannabinoids Market Revenue Share, By Region, 2019 & 2026 (USD Million)
    • 8.2. North America
      • 8.2.1. North America Synthetic Cannabinoids Market Revenue 2016 – 2026 (USD Million)
      • 8.2.2. North America Synthetic Cannabinoids Market Revenue, By Product Type, 2016 – 2026 (USD Million)
      • 8.2.3. North America Synthetic Cannabinoids Market Revenue, By Indication, 2016 – 2026 (USD Million)
      • 8.2.4. North America Synthetic Cannabinoids Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.2.5.2. U.S. Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.2.5.3. U.S. Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.2.6. Canada
        • 8.2.6.1. Canada Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.2.6.2. Canada Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.2.6.3. Canada Education & Learning Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.2.7. Mexico
        • 8.2.7.1. Mexico Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.2.7.2. Mexico Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.2.7.3. Mexico Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Synthetic Cannabinoids Market Revenue 2016 – 2026 (USD Million)
      • 8.3.2. Europe Synthetic Cannabinoids Market Revenue, By Product Type, 2016 – 2026 (USD Million)
      • 8.3.3. Europe Synthetic Cannabinoids Market Revenue, By Indication, 2016 – 2026 (USD Million)
      • 8.3.4. Europe Synthetic Cannabinoids Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.5.2. UK Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.5.3. UK Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.6.2. France Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.6.3. France Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.7.2. Germany Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.7.3. Germany Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.8. Italy
        • 8.3.8.1. Italy Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.8.2. Italy Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.8.3. Italy Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.9. Spain
        • 8.3.9.1. Spain Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.9.2. Spain Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.9.3. Spain Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.10. Russia
        • 8.3.10.1. Russia Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.10.2. Russia Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.10.3. Russia Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.11. Rest of Europe
        • 8.3.11.1. Rest of Europe Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.3.11.2. Rest of Europe Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.3.11.3. Rest of Europe Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Synthetic Cannabinoids Market Revenue 2016 – 2026 (USD Million)
      • 8.4.2. Asia Pacific Synthetic Cannabinoids Market Revenue, By Product Type, 2016 – 2026 (USD Million)
      • 8.4.3. Asia Pacific Synthetic Cannabinoids Market Revenue, By Indication, 2016 – 2026 (USD Million)
      • 8.4.4. Asia Pacific Synthetic Cannabinoids Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.5.2. China Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.5.3. China Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.6.2. Japan Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.6.3. Japan Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.7.2. India Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.7.3. India Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.8. Australia
        • 8.4.8.1. Australia Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.8.2. Australia Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.8.3. Australia Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.9. South Korea
        • 8.4.9.1. South Korea Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.9.2. South Korea Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.9.3. South Korea Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.10. Rest of Asia Pacific
        • 8.4.10.1. Rest of Asia Pacific Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.4.10.2. Rest of Asia Pacific Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.4.10.3. Rest of Asia Pacific Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Synthetic Cannabinoids Market Revenue 2016 – 2026 (USD Million)
      • 8.5.2. Latin America Synthetic Cannabinoids Market Revenue, By Product Type, 2016 – 2026 (USD Million)
      • 8.5.3. Latin America Synthetic Cannabinoids Market Revenue, By Indication, 2016 – 2026 (USD Million)
      • 8.5.4. Latin America Synthetic Cannabinoids Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.5.5.2. Brazil Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.5.5.3. Brazil Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.5.6.2. Argentina Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.5.6.3. Argentina Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.5.7.2. Rest of Latin America Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.5.7.3. Rest of Latin America Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Synthetic Cannabinoids Market Revenue 2016 – 2026 (USD Million)
      • 8.6.2. Middle East & Africa Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
      • 8.6.3. Middle East & Africa Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
      • 8.6.4. Middle East & Africa Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.6.5. GCC Countries
        • 8.6.5.1. GCC Countries Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.6.5.2. GCC Countries Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.6.5.3. GCC Countries Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.6.6.2. South Africa Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.6.6.3. South Africa Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.6.7. Rest of MEA
        • 8.6.7.1. Rest of MEA Synthetic Cannabinoids Market Revenue, by Product Type, 2016 – 2026 (USD Million)
        • 8.6.7.2. Rest of MEA Synthetic Cannabinoids Market Revenue, by Indication, 2016 – 2026 (USD Million)
        • 8.6.7.3. Rest of MEA Synthetic Cannabinoids Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Mylan N.V.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfulio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. *Same information will be provided for below mentioned companies*
      • 9.2.1. Noramco, Lygos, Inc.
      • 9.2.2. Alkem Labs
      • 9.2.3. BOTANIX PHARMACEUTICALS
      • 9.2.4. Hyasynth Biulogicals, Inc.
      • 9.2.5. INSYS THERAPEUTICS, INC
      • 9.2.6. Renew Biopharma
      • 9.2.7. CannBioRx Life Sciences
      • 9.2.8. Ginkgo Bioworks
      • 9.2.9. CURE Pharmaceutical
      • 9.2.10. Aphios Corporation
      • 9.2.11. Zynerba Pharmaceuticals, Inc
      • 9.2.12. Others

Methodology


Frequently Asked Questions

The growth of global demand for synthetic cannabinoids is anticipated to position its demands on the regulatory framework for the use of synthetic cannabinoid drugs. The rising popularity of e-cigarettes combined with the increasing inclination to the use of synthetic cannabinoids as a replacement to non-synthetic cannabis in many parts of the world is expected to provide a major boost to the use of synthetic cannabinoids. Increased consumer awareness and growth for non-regulated psychoactive substances over the last few years is projected to fuel the global synthetic cannabinoids market during the forecast era. The need for synthetic cannabinoids to determine the possible effect of a wide variety of diseases and symptoms, particularly neurodegenerative diseases, drug dependency, cancer, and pain disorders is another significant factor likely to drive the demand for global synthetic cannabinoids market.

According to Zion Market Research, the Synthetic Cannabinoids market is expected to generate revenue of around USD 7,556.9 Million by the end of 2026, growing at a CAGR of 21.76%.

The demand for synthetic cannabinoids in North America is expected to develop rapidly during the forecast timeframe. This can be due to the large availability of products and the continuous promotion of its brand among medical professionals in the region by the involvement of major companies. In Europe, the global synthetic cannabinoids market is anticipated to grow at a significant pace, due to an increase in the use of synthetic cannabinoids among cancer patients and increased knowledge of therapy, particularly in developed countries in Europe where research and development activities are strong, such as Germany, the United Kingdom and France. In Asia-Pacific, India and China are leading pharmaceutical and drug markets where synthetic cannabinoid approval for pharmaceutical formulations may play a major role in promoting the sales of synthetic cannabinoids in the region.

The major players in the global synthetic cannabinoids market include Mylan N.V., Noramco, Lygos, Inc., Alkem Labs, BOTANIX PHARMACEUTICALS, Hyasynth Biologicals, Inc., INSYS THERAPEUTICS, INC, Renew Biopharma, CannBioRx Life Sciences, Ginkgo Bioworks, CURE Pharmaceutical, Aphios Corporation, and Zynerba Pharmaceuticals, Inc. among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com